Compared with the control, the level of TNF-α in the AR group significantly decreased after treatment (p < 0.05), which suggested that the neuroprotective effects of AR may be related to the inhibition of neurogenic inflammation caused by cerebral ischemia. The gene discussed is TNF; the disease is Cerebral ischemia.